# Q500B verification review: s75, Headache (after revision 2)

Reviewer: fresh independent QA agent. I did not write, edit or review this batch before. Both lenses (clinical truth, internal consistency and cueing). File reviewed in full: `src/samps/s75/headache.ts`, ids headache-48 to headache-52, against the first review `docs/reviews/q500b-qa-s75.md` and the writer report `docs/reviews/q500b-writer-s75.md` (revisions 1 and 2). No edits made (REVIEW-RULES rule 1).

## Checks run

- `npx tsc --noEmit -p . 2>&1 | grep samps/s75` prints nothing.
- `SAMP_BATCH=s75 npx vitest run tests/samps.test.ts tests/samp-quality.test.ts tests/citations.test.ts --testTimeout=120000`: 128 of 128 pass.
- House style: no em dashes, en dashes or semicolons in content. Canadian spelling (tumour, manoeuvres, pseudotumour). No personal names. No mnemonics.
- Position balance of the 19 single keys: first 4, second 4, third 4, fourth 4, fifth 3. No position above 25 percent.
- Key feature coverage: n1 3, n2 3, n3 4, n4 6, n5 3, n6 1. Every key feature tested. Five SAMPs kept.
- Whole bank keyword search (src/samps and src/cases, all batches including s72 to s88 and batch16 to batch20): occipital neuralgia, occipital nerve, nerve block, cervicogenic, stabbing headache, allodynia, craniocervical, long tract, leptomeningeal, carcinomatous, Gradenigo, petrous, cardiac cephalalgia, exertion with headache, breastfeed, lactation, LactMed, dihydroergotamine, pump and discard. Findings: occipital neuralgia appears only as a distractor in s40 headache-25 (cough headache), with "Pain with neck rotation suggests a cervical source" as a one-line distractor reason there. That is a different decision, not a repeat. No item keys a nerve block for headache. Breastfeeding items elsewhere are antihypertensives (s82, batch13), CT contrast (s73 dvt-pe) and methadone (s83 tox), not migraine drugs. No other Q500B batch has a headache file. No repeat found.

## Sources verified (opened this review)

- ICHD-3 13.4 Occipital neuralgia (opened by curl, the cited URL returns 301 to https://ichd-3.org/13-painful-cranial-neuropathies-and-other-facial-pains/13-4-occipital-neuralgia/ and the page loads): description "sometimes accompanied by diminished sensation or dysaesthesia ... commonly associated with tenderness", criteria B to D including allodynia on the scalp or hair, trigger points at the emergence of the greater occipital nerve, relief by local anaesthetic block, comment on fronto-orbital spread through trigeminocervical connections, comment that it must be told apart from referral from the atlantoaxial or upper zygapophyseal joints. Supports 49 q1, q2 and q4. Optional tidy-up, not a fail: point the URL at the canonical address.
- ICHD-3 4.7 Primary stabbing headache (https://ichd-3.org/other-primary-headache-disorders/4-7-primary-stabbing-headache/): "When stabs are strictly localized to one area, structural changes at this site and in the distribution of the affected cranial nerve must be excluded." Supported.
- ICHD-3 11.2.1 Cervicogenic headache: criterion C3 "cervical range of motion is reduced and headache is made significantly worse by provocative manoeuvres". Supported.
- ICHD-3 10.6 Cardiac cephalalgia: parallel worsening and improvement with ischemia, nausea, no photophobia or phonophobia, aggravated by exertion, relieved by nitroglycerine, serious consequences if missed, triptans and ergots contraindicated in ischemic heart disease. Supported.
- Blumenfeld 2013 AHS peripheral nerve blocks (PubMed 23406160): cranial neuralgias among indications, greater occipital block described, cutaneous anesthesia as technical success, anticoagulant use as a special consideration, sparse evidence outside cluster headache. Supported, citation details correct.
- Orr 2015 CHS emergency migraine (PubMed 24875925): metoclopramide strong for, ketorolac strong for (low evidence), dihydroergotamine weak for, dexamethasone strong against, morphine and tramadol weak against. Consistent with 50 q2 and q4 explanations.
- Do 2019 SNNOOP10 (PubMed 30587518): real, sudden or abrupt onset is a listed flag. Supported.
- LactMed through PubMed: dihydroergotamine (PMID 34554670, 2021: no data, most authorities consider ergots contraindicated, nasal spray manufacturer advises no breastfeeding during treatment and for 3 days, discard pumped milk), sumatriptan (PMID 30000314, 2025: low milk levels, poor oral bioavailability, manufacturer advises withholding 12 hours, withholding "might be helpful in extreme cases, such as in the mother of a preterm infant", "has been recommended as a triptan of choice"), ketorolac (PMID 30000057: manufacturer contraindicates in breastfeeding, alternate drug preferred after 24 to 72 hours). Supported, see 50 q4.
- CPS acute otitis media (https://cps.ca/en/documents/position/acute-otitis-media, reaffirmed 21 November 2024): pain or swelling over the mastoid bone behind the ear suggests mastoiditis, sixth nerve palsy from petrous bone infection (Gradenigo), facial palsy. Also notes AOM usually involves the mastoid air cells, which supports the 51 q4 explanation's "ear and mastoid infection he already has".
- Schmit 2025 (https://pmc.ncbi.nlm.nih.gov/articles/PMC12428227/): triad 22%, meningeal enhancement 27%, third-generation cephalosporins most used and the only regimen with fewer complications (p = 0.016), surgery 72%. Supported.

Not opened by me: EANO-ESMO 2023 (PMC10619142) and ESC 2023 ACS full text. The first review verified EANO-ESMO, and I found nothing in the 48 text that goes beyond what it reported. The ESC claim (dynamic ST or T changes as a high-risk criterion for an early invasive strategy within 24 hours) matches my knowledge of the guideline. Europe PMC search was returning 503, and the Schmit venous sinus thrombosis 15% figure and the one death were not re-located in my text extract (first review confirmed them).

## First-review fails: resolution

| First-review fail | Resolved? |
|---|---|
| 48 q1 sleep apnea called primary | Yes, wording as prescribed |
| 48 q2 grammar cue | Yes, key "Multiple lesions on both sides", correct 2, alphabetical order holds |
| 48 q3 back pain update cue | Yes, update and explanation as prescribed |
| 49 zoster retelling | Yes, replaced by occipital neuralgia. No zoster, antiviral or contact content remains |
| 50 q1 onset fact and cue | Yes, onset in stem, cueing sentence gone, explanation matches |
| 50 q2 repeat of headache-17 q2 | Yes, dropped, SAMP has 4 questions |
| 50 q5 sumatriptan manufacturer advice | Added (now q4), but the added sentence misattributes LactMed, see 50 q4 |
| 51 q2 cue and pontine glioma reason | Yes, both |
| 51 q4 ceftriaxone cue | Yes |
| 52 q4 nitroglycerin cue | Yes |

Unrequested writer changes judged on merit (REVIEW-RULES rule 4): 48 q3 brainstem infarction replacing myasthenia, with a true reason (sudden onset, no bilateral accrual over weeks): accepted. 50 q3 "Wait 6 hours, then breastfeed": accepted, explanation covers it. 51 q4 key "Neck stiffness and drowsiness": accepted. 52 q1 "Pain worse when lying down": accepted, reason true. 52 q3 morphine replacing sumatriptan: accepted, the triptan contraindication is still taught.

## Verdicts

### headache-48 Leptomeningeal metastasis

| Q | Verdict | Finding and exact fix | Confidence |
|---|---|---|---|
| q1 | PASS | Key and reasons true. | n/a |
| q2 | PASS | Localisation correct (right VI, left V3, left LMN VII). CPA reason and cerebral lesion reason true. | n/a |
| q3 | PASS | Key correct. Reasons true. "Would be expected to affect limb strength and reflexes" is suitably hedged for GBS. | n/a |
| q4 | PASS | Key matches EANO-ESMO. Mock-mode cue from the options to q3 stays flagged (B6, unavoidable). | n/a |

### headache-49 Occipital neuralgia (new)

New angle, no repeat in the bank. Clinical content matches ICHD-3 13.4, 4.7 and 11.2.1 and the AHS consensus. Options alphabetical. The defects are cueing and wording.

| Q | Verdict | Finding and exact fix | Confidence |
|---|---|---|---|
| q1 | FAIL | Lead-in mismatch (ruling B8). The prompt asks for "examination findings", but "Pain spreading toward the left eye" is a history feature. Fix: change the prompt to "Which of the following findings would most suggest a secondary cause that needs investigation?" | low |
| q2 | FAIL | Two defects. (1) Mock-mode cue (B6): the q2 update "Arm strength and reflexes are normal." names the q1 key (left arm weakness, brisk reflexes). q2 does not need it. Fix: replace that sentence with "The rest of his neurological examination is normal." (2) The explanation says the findings "meet the ICHD-3 criteria for occipital neuralgia", but criterion D (relief by local anaesthetic block) is not yet met at this point. Fix: change "meet the ICHD-3 criteria for occipital neuralgia." to "meet the ICHD-3 clinical criteria for occipital neuralgia, which are completed when a local anesthetic block of the nerve eases the pain." | high (1), low (2) |
| q3 | FAIL | Mock-mode cue (B6): the option "Greater occipital nerve block" names the q2 key (occipital neuralgia), and a neutral wording exists, so B6 says reword. Fix: change the option to "Anesthetic nerve block" (it stays first alphabetically, `correct` stays 0, it is not the longest option, and position balance is unchanged). Keep the explanation's first sentence, which names the greater occipital nerve. | medium |
| q4 | FAIL | Mock-mode cue (B6): the update "Within 10 minutes the attacks stop and the skin over the left occiput is numb." describes skin numbness after treatment, which the q3 explanation itself calls the sign of a successful nerve block, so it gives away the q3 key. Fix: change the update to "His attacks stop within 10 minutes of treatment. He asks whether a problem in his neck could be the cause." Note for the physician: the q4 options (scalp allodynia, trigger point at the nerve exit) also hint at the q2 diagnosis in mock mode. q4 cannot work without them, so per B6 it stays and is flagged. | medium |

Note, not a fail: q3 (treatment) mapped to key feature 4 is a loose fit, but the block is also diagnostic, so it is acceptable.

### headache-50 Migraine while breastfeeding

| Q | Verdict | Finding and exact fix | Confidence |
|---|---|---|---|
| q1 | PASS | Stem now states gradual onset. Explanation consistent. No cue left in later updates. | n/a |
| q2 | PASS | Metoclopramide keyed correctly per CHS (strong). Ketorolac is also strongly recommended by CHS, but the explanation correctly rejects it on the manufacturer's breastfeeding contraindication, and LactMed prefers an alternative after the first 24 to 72 hours postpartum (she is 5 months postpartum). Doses correct. | n/a |
| q3 | PASS | Key matches LactMed (3 days, discard milk). Option order 3 days before 12 hours follows numeric order, which the tests accept. | n/a |
| q4 | FAIL | The sentence added in revision 2 says LactMed "recommends it as a triptan of choice". LactMed reports that sumatriptan "has been recommended as a triptan of choice" by other authors, and the first sentence already says it is preferred, so the point is repeated and misattributed. Fix: replace the first two sentences with "LactMed notes that sumatriptan has been recommended as a triptan of choice during breastfeeding, because milk levels are low, it is poorly absorbed by the infant by mouth and adverse effects are not expected in most breastfed infants. Its manufacturer advises withholding breastfeeding for 12 hours after a dose, but LactMed suggests this only in extreme cases, such as the mother of a preterm infant." | low |

### headache-51 Petrous apicitis in a child, remote northern hospital

| Q | Verdict | Finding and exact fix | Confidence |
|---|---|---|---|
| q1 | PASS | Key matches CPS. | n/a |
| q2 | PASS | Cue removed. DIPG reason now true (cranial nerve palsy, long tract signs, ataxia). | n/a |
| q3 | PASS | IV ceftriaxone before the flight is correct. Schmit favours a third-generation cephalosporin, often with a nitroimidazole. Ceftriaxone alone as the first dose is still the single best option here. | n/a |
| q4 | PASS | Cue removed. Key and reasons true. "Ear and mastoid infection he already has" is supported by CPS (AOM usually involves the mastoid air cells). | n/a |

### headache-52 Cardiac cephalalgia labelled as migraine

| Q | Verdict | Finding and exact fix | Confidence |
|---|---|---|---|
| q1 | PASS | Key and reasons match ICHD-3 10.6. | n/a |
| q2 | PASS | ECG first correct. The q3 update cue to the q2 key stays flagged (B6, unavoidable). | n/a |
| q3 | PASS | Nitroglycerin correct, BP 154/90 safe, no PDE5 inhibitor listed. Morphine reason true. | n/a |
| q4 | PASS | Cue removed. Key consistent with ESC 2023. Overlap with ischemic-heart-disease-02 q3 already noted by the first review (different deciding fact). | n/a |

## Key changes

None made (reviewers do not edit).

## Needs physician decision

- B6 unavoidable mock-mode cues, left and flagged: headache-48 q4 options (cue q3), headache-52 q3 update (cues q2), headache-49 q4 options (hint at the q2 diagnosis).

## Writer uncertainties checked

- 48 q3 reasons against GBS, brainstem infarction and GCA: true.
- 48 q1 and 50 q1 test different history skills: accepted.
- 49 nerve block evidence is mostly consensus: confirmed by the AHS abstract. The key holds as the best ED option among those offered. Reasons against oxygen, triptans, metoclopramide and opioids are true.
- 49 q2 naming cervicogenic headache with q4 asking about it: q4 does not reveal the q2 key and q2 does not reveal the q4 key. Accepted.
- 50 q3 (pump and discard 3 days): supported by LactMed. Codeine wording in q4 accepted as reported by the first review.
- 50 q2 and q4 single-source citations: acceptable.
- 52 q4 ESC claim: correct to my knowledge, full text not opened.

## Summary

5 SAMPs, 20 questions (19 single, 1 menu). Every first-review fail is resolved, except that the 50 q4 sentence added to fix one needs rewording. headache-48, 51 and 52 pass in full. The new headache-49 is a sound, original occipital neuralgia SAMP with true content, but three mock-mode cues (q2 update names the q1 key, q3 option names the q2 key, q4 update gives away the q3 key), a lead-in mismatch in q1 and an overclaim in the q2 explanation. headache-50 q4 misattributes a LactMed statement.

Fails: headache-49 q1, q2, q3, q4, headache-50 q4.

Overall: FAIL (5 items)
